Trials / Completed
CompletedNCT04205097
Deep vs Moderate Neuromuscular Blocks on Remifentanil for Laparoscopic Gastrectomy
Deep Versus Moderate Neuromuscular Blocks on Remifentanil Requirements in Patients Undergoing Surgical Pleth Index-guided Analgesia for Laparoscopic Gastrectomy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Ajou University School of Medicine · Academic / Other
- Sex
- All
- Age
- 19 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose is to compare the remifentanil requirements in deep vs moderate neuromuscular blocks during the surgical pleth index -guided anesthesia in patients undergoing laparoscopic gastrectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Neostigmine + glycopyrate | maintaining of moderate neuromuscular block (train-of-four count 1-2) during surgery, reversal using neostigmine 50 ug/kg and glycopyrrolate 10 ug/kg |
| DRUG | Sugammadex | maintaining of deep neuromuscular block (posttetanic count 1-2) during surgery, reversal using sugammadex 2-4 mg/kg |
Timeline
- Start date
- 2019-12-23
- Primary completion
- 2020-12-02
- Completion
- 2020-12-02
- First posted
- 2019-12-19
- Last updated
- 2020-12-17
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04205097. Inclusion in this directory is not an endorsement.